Page last updated: 2024-10-30

metaproterenol and Urination Disorders

metaproterenol has been researched along with Urination Disorders in 2 studies

Metaproterenol: A beta-2 adrenergic agonist used in the treatment of ASTHMA and BRONCHIAL SPASM.
orciprenaline : A racemate composed of equimolar amounts of (R)- and (S)-orciprenaline. Used (as its sulfate salt) to relax the airway muscles and improve breathing for patients suffering from asthma or bronchitis.
5-[1-hydroxy-2-(isopropanylamino)ethyl]benzene-1,3-diol : A member of the class of resorcinols bearing an additional 1-hydroxy-2-(isopropanylamino)ethyl substituent at position 5 of resorcinol itself.

Urination Disorders: Abnormalities in the process of URINE voiding, including bladder control, frequency of URINATION, as well as the volume and composition of URINE.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fiorentini, L1
Aragona, F1
van der Bijl, WJ1

Other Studies

2 other studies available for metaproterenol and Urination Disorders

ArticleYear
[Urinary retention following the use of beta-stimulating agents in obstetrics: physiopathological considerations and description of a case].
    Rivista italiana di ginecologia, 1980, Volume: 59, Issue:2-3

    Topics: Adrenergic beta-Agonists; Adult; Female; Humans; Metaproterenol; Obstetric Labor, Premature; Pregnan

1980
[3 case reports].
    Nederlands tijdschrift voor geneeskunde, 1971, Mar-06, Volume: 115, Issue:10

    Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Aged; Asthma; Child; Ethics, Medical; Humans; Male;

1971